The global lymphoma treatment market size was valued at USD 7.41 billion in 2024 and is projected to reach USD 11.97 billion by 2030, growing at a CAGR of 8.3% from 2025 to 2030. The market expansion is primarily driven by the increasing incidence of lymphoma, particularly non-Hodgkin lymphoma, which has created a heightened need for effective and targeted treatment options....